Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues – Blood proteins or globulins – e.g. – proteoglycans – platelet...
Patent
1989-12-27
1992-08-25
Nucker, Christine M.
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
Blood proteins or globulins, e.g., proteoglycans, platelet...
5303889, 53038822, 5303888, 5303917, 514 2, 435972, 435 71, 43524026, 435 7021, 4351722, 43524027, 424 858, 424 8591, A61K 3900, A61K 3514, C12Q 100, G01N 3353
Patent
active
051417367
ABSTRACT:
The present invention discloses, a bispecific monoclonal antibody to an ansamitocin derivative and a target antigen, particularly tumor-associated antigen, which can carry an anasamitocin derivative in a stable and inactive form at other sites than the target and release the active-form ansamitocin derivative at the target site, so that an anticancer agent having excellent durability and selectivity with little adverse action can be prepared using the bispecific monoclonal antibody and ansamitocin derivatives.
REFERENCES:
patent: 4474893 (1984-10-01), Reading
patent: 4713352 (1987-12-01), Bander et al.
patent: 4714681 (1987-12-01), Reading
patent: 4727021 (1988-02-01), Cate et al.
patent: 4962188 (1990-10-01), Frankel
Ghosh et al (1987) Tumor Markers & Tumor Associated Antigens, McGraw Hill, NY, pp. 239-269.
Corvalan et al (1987) Specific in vitro & in vivo drug--Cancer Immunol Immunoether 24:133-137.
Corvalan et al (1987) Increased theraputic effect--Cancer Immunol Immunoether 24:138-143.
Pirker et al et al (1985) Anti Transferrin Receptor Antibody-Cancer Res 45:751-757.
Wong et al (1987) Bispecific Monoclonal Antibody--J Immunol 139:1369-1475.
Wilstein et al (1983) Hybridhybridomas--nature 305: 537-540.
Kawac et al (1984) (Abstract & Associated Materials) Chemical modification--Chem Pharm Bull 32: 3441-3451.
Corvalan et al (1987) Construction & Charact.--Cancer Immunol Immunother 24: 127-132.
Iwasa, et al., The Physio-Chemical Biology, vol. 32, No. 5, p. 225(1988).
Harada Kaori
Iwasa Susumu
Toyoda Yukio
Conlin David G.
Nucker Christine M.
Preston David R.
Resnick David S.
Takeda Chemical Industries Ltd.
LandOfFree
Bispecific monoclonal antibody, its production and use does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Bispecific monoclonal antibody, its production and use, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Bispecific monoclonal antibody, its production and use will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-383412